Clinical Data Announces Positive Results from Phase III Pivotal Trial of Vilazodone for Depression
Potential Genetic Biomarkers for Predicting Response to Vilazodone Identified
06-Sep-2007 -
Clinical Data, Inc. announced positive results in its pivotal Phase III study of its investigative compound Vilazodone. In the study, the primary and supportive secondary efficacy endpoints were met. In addition, the study separately identified candidate biomarkers for a potential companion ...
antidepressants
biomarkers
depressions
+4